Can dietary supplementation with Krill-Oil improve Myalgia Encephalomyelitis/Chronic Fatigue Syndrome symptoms in Adults?

Deakin University0 个研究点目标入组 160 人开始时间: 2022年9月14日最近更新: 2022年9月19日

适应症

试验速览

暂无简介。

•1. Aged 18 and above, either male or female.
•2. Clinically diagnosed with ME/CFS by an independent physician and fulfil the criteria for ME/CFS using the Multidimensional fatigue inventory (MFI-20).
•3. Participants currently under any form of therapy for ME/CFS will need to have been on that therapy for at least 8 weeks prior to enrolment.
•3. Ability to consent to the study and comply with study procedures as ascertained by research interviewer.
•4. English speaker

•1. Aged <18
•2Medical condition that explains chronic fatigue (untreated hypothyroidism, sleep apnea, narcolepsy, medication side effects, and diagnosed iron deficiency)
•3. Previous diagnosis not resolved (chronic hepatitis, malignancy)
•5. Known or suspected systemic medical disorder such as rheumatoid arthritis or any serious medical condition (e.g. cognitive disorder, intellectual disability, Alzheimer’s disease).
•6. Current diagnosis of a psychotic disorder, bipolar disorder, substance abuse/dependence, eating disorder, or significant personality disorder
•7. Participation in another trial within 30 days prior to study inclusion
•8. Inability to be randomised to a treatment arm
•9. Inability to provide written informed consent
•10.Medications/supplements that might influence nutrient absorption or outcome measures in the last 90 days
•11. Patients on blood thinning medication or at risk of bleeding
•12. Pregnant or breast-feeding
•13. Smoking, substance/alcohol abuse
•14. Allergy to shellfish or never consumed shellfish (to avoid those with an unknown allergy).

发起方